| 5.145 0.055 (1.08%) | 04-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7.41 |
1-year : | 8.39 |
| Resists | First : | 6.35 |
Second : | 7.18 |
| Pivot price | 5.78 |
|||
| Supports | First : | 5 |
Second : | 4.15 |
| MAs | MA(5) : | 5.31 |
MA(20) : | 5.76 |
| MA(100) : | 6.49 |
MA(250) : | 7.62 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 2.6  |
D(3) : | 4.7 |
| RSI | RSI(14): 37.9 |
|||
| 52-week | High : | 14.44 | Low : | 4.28 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ HSDT ] has closed above bottom band by 11.5%. Bollinger Bands are 10.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.16 - 5.19 | 5.19 - 5.22 |
| Low: | 4.92 - 4.96 | 4.96 - 5 |
| Close: | 5.08 - 5.15 | 5.15 - 5.21 |
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
Wed, 03 Apr 2024
Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of ... - GlobeNewswire
Wed, 03 Apr 2024
Why Is Helius Medical Stock Trading Higher Today? - Helius Medical Tech (NASDAQ:HSDT) - Benzinga
Mon, 01 Apr 2024
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q4 2023 Earnings Call Transcript - Yahoo Finance
Thu, 28 Mar 2024
HSDT Stock Earnings: Helius Medical Tech Beats EPS, Misses Revenue for Q4 2023 - InvestorPlace
Thu, 28 Mar 2024
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results - Yahoo Finance
Tue, 05 Mar 2024
Helius Medical shares target raised to $24 on CMS code assignment - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 829470 (%) |
| Held by Institutions | 0.8 (%) |
| Shares Short | 36 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.211e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 676.1 % |
| Return on Equity (ttm) | -61.5 % |
| Qtrly Rev. Growth | 644000 % |
| Gross Profit (p.s.) | -33.88 |
| Sales Per Share | -108.75 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -14.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.05 |
| Price to Cash Flow | 2.42 |
| Dividend | 0 |
| Forward Dividend | 72190 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|